Document Preview Unavailable

A pooled analysis of clinical outcome in driver-gene negative non-small cell lung cancer patients with MET overexpression treated with gumarontinib

Yu, Yongfeng; Dong, Wen; Shi Yanxia; Wu, Rong; Yu Qitao; et al.  Therapeutic Advances in Medical Oncology Vol. 16,  (Jan 2024).

You might have access to this document